Philips Launches IntelliVue PM 6000, an Entry-Level Patient Monitor Range
Philips is expanding its patient monitor portfolio by introducing on Wednesday an entry-level solution aimed at facilities facing budgetary and operational constraints. The IntelliVue Patient Monitor 6000 Series combines measurement flexibility and connectivity options to meet the needs of rural hospitals and ambulatory surgery centers.
The PM 6000 Series is based on an 'integrated measurements plus expansion' architecture: three models offer built-in basic parameters, complemented by two technological innovations. The IntelliVue Measurement Rack 6000 utilizes existing IntelliVue modules to quickly extend monitoring capabilities without replacing equipment. The new Flexible Link technology, a first for Philips, introduces standardized connectors allowing for the addition of measurements post-purchase through a new generation of compatible modules across monitors. This modularity relies on the same IntelliVue software as the MX line, facilitating clinical adoption and integration into existing infrastructures.
The standardized, all-in-one design of the PM 6000 Series aims to simplify deployment, training, and maintenance. The streamlined design also supports cleaning protocols and infection control, critical issues in hospital environments.
Progressive Connectivity for Organizations in Digital Transition
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The PM 6000 Series offers several deployment modes: standalone monitor use, direct connection to the electronic medical record via HL7 protocol, or integration into the Philips patient monitoring enterprise ecosystem. When integrated into an existing Philips fleet, the PM 6000 Series reuses supplies from established MX monitors, reducing transition costs.
This connectivity flexibility directly addresses the challenges faced by rural hospitals and ambulatory surgery centers: it reconciles budgetary pressure, staff shortages, and increasing patient complexity, while modernizing workflows and preparing for future connectivity advancements.
SectorDispositifs médicaux et optique›Dispositifs médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: T3 2026
Key reported figures
Revenue: 4 393 millions d'euros
Quarterly revenue: 4 393 millions d'euros
Revenue growth: 2 %
Net income: 27 millions d'euros
Free cash flow: 384 millions d'euros
5 387 millions d'euros
Guidance from the release
« Our year-to-date results, together with our strong order book, give us confidence in delivering our full-year outlook and achieving our medium-term ambitions. » ; « Philips reiterates its full-year 2026 outlook »
Risks mentioned
Macro-economic and geopolitical changes including war in Ukraine and Middle East tensions, plus enacted and proposed tariffs and trade actions
Respironics-related legal proceedings and ongoing investigation by US State Attorneys General excluded from 2026 outlook
Phasing of Ultrasound sales and lower sales in China as previously communicated at Q2
Opportunities identified
Strong demand for latest AI-enabled innovations including new CT platforms Verida and Rembra, ultrasound system Alturion, and HealthSuite Imaging cloud solution
Accelerating innovation in image-guided therapy with EUR 50 million investment in AI, robotics and advanced imaging in Netherlands, plus EUR 150 million in private financing
Extended monitoring partnership with largest US health system through 2034 and expansion of Capsule platform, plus strategic partnerships in China and Latin America
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.